GLP-Compliant Services (Regulatory)
Good Laboratory Practice (GLP) services from GENEWIZ are designed to be compliant with US FDA (21 CFR Part 58) and US EPA (40 CFR Part 160) regulations to support pre-marketing authorizations.
Good Laboratory Practice (GLP) services from GENEWIZ are designed to be compliant with US FDA (21 CFR Part 58) and US EPA (40 CFR Part 160) regulations to support pre-marketing authorizations.
Clinical Genome Sequencing provides a CLIA-validated comprehensive analysis of the entire genome to uncover mutations in coding and non-coding regions, including structural and copy number variants.
Clinical Exome Sequencing is a CLIA-validated method to probe protein-coding regions of the genome at high depth and with uniform coverage. Our regulatory service provides whole exome sequencing services in our GCP-compliant, CAP-accredited laboratory.
GENEWIZ provides CLIA Sanger sequencing as the clinical "gold standard" from our state-of-the-art CLIA-certified and CAP-accredited laboratory.
CLIA variant confirmation via PCR + Sanger sequencing is used to detect or confirm mutations within genomic DNA.
To support pre-clinical and clinical regulatory submissions, GENEWIZ has established Good Laboratory Practices (GLP) and Clinical Laboratory Improvement Amendments (CLIA)-compliant workflows.
GENEWIZ AAV Plasmid Preparation service delivers superior quality for midi to giga-scale AAV vectors, while maintaining the integrity of ITR regions.
GENEWIZ Targeted Yield Plasmid DNA Preparation Service delivers specific quantities of high quality, transfection-grade DNA that you can count on.
GENEWIZ Standard Plasmid DNA Preparation Service is a flexible and fast choice for a range of plasmid templates.
GENEWIZ Plasmid Prep Services provide high-quality plasmids from microgram- to gram-scale with reliable and fast turnaround times to accommodate tight deadlines.